(19)
(11) EP 3 509 559 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.07.2023 Bulletin 2023/29

(45) Mention of the grant of the patent:
07.06.2023 Bulletin 2023/23

(21) Application number: 17848293.1

(22) Date of filing: 07.09.2017
(51) International Patent Classification (IPC): 
A61L 27/52(2006.01)
(52) Cooperative Patent Classification (CPC):
A61Q 19/08; A61K 8/735; A61K 8/042; A61K 8/24; A61K 2800/80; A61L 27/52; A61L 2400/06; A61L 2430/34; A61L 2430/40; A61L 27/46
 
C-Sets:
A61L 27/46, C08L 5/08;
(86) International application number:
PCT/IL2017/051019
(87) International publication number:
WO 2018/047182 (15.03.2018 Gazette 2018/11)

(54)

METHODS OF MANUFACTURING INJECTABLE GELS COMPRISING CROSS-LINKED HYALURONIC ACID AND HYDROXYAPATITE

VERFAHREN ZUR HERSTELLUNG VON INJIZIERBAREN GELEN MIT VERNETZTER HYALURONSÄURE UND HYDROXYAPATIT

MÉTHODES DE FABRICATION DE GELS INJECTABLES COMPRENANT DE L'ACIDE HYALURONIQUE RÉTICULÉ ET DE L'HYDROXYAPATITE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 07.09.2016 US 201662384219 P

(43) Date of publication of application:
17.07.2019 Bulletin 2019/29

(60) Divisional application:
23171103.7

(73) Proprietor: Allergan Pharmaceuticals International Limited
Dublin 17, D17 E400 (IE)

(72) Inventors:
  • SEGAL, David Dadi
    6436805 Tel Aviv (IL)
  • GOLDBERG, Eran
    5259321 Ramat Gan (IL)
  • SHKLANOVSKY, Lital
    5540101 Kiryat Ono (IL)
  • ZINGER, Ariel
    5248501 Ramat Gan (IL)
  • GOLDSHAID-ZMIRI, Liat
    4976001 Petach Tikva (IL)

(74) Representative: Russell, Tim 
Venner Shipley LLP 200 Aldersgate
London EC1A 4HD
London EC1A 4HD (GB)


(56) References cited: : 
WO-A1-2013/053457
WO-A1-2017/045084
US-A1- 2015 257 989
 WO-A1-2016/074794
US-A1- 2015 238 525
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).